| Literature DB >> 35153727 |
Ayasa Takamino1, Masakazu Kotoda1, Yosuke Nakadate1, Sohei Hishiyama1, Tetsuya Iijima1, Takashi Matsukawa1.
Abstract
As the world is rapidly aging, and the number of elderly patients who undergo surgery is rising, postoperative cognitive decline among those patients has become an increasing healthcare problem. Although understanding the risk factors and mechanisms underlying the pathogenesis of postoperative cognitive decline is critically important from a preventative viewpoint, such knowledge and evidence are lacking. A growing body of evidence suggest an association between cognitive function and sleep duration. The purpose of this study was to investigate the association between postoperative cognitive function and sleep duration on the night before surgery using a wearable sleep tracker. In this 6-month prospective cohort study, we analyzed data from 194 patients aged ≥ 65 years who underwent elective non-cardiac and non-cranial surgery under general anesthesia. According to the sleep duration on the night before surgery, patients were categorized into following four groups: <5, 5-7, 7-9, and >9 h. Perioperative cognitive function and domains were assessed using a neuropsychological test battery, and the incidence and prevalence of cognitive decline over 6 months after surgery were analyzed using the multiple logistic regression analysis. During the 6-month follow-up period, 41 patients (21%) developed cognitive decline. The incidence of cognitive decline was significantly elevated for the patients with sleep duration < 5 h (vs. 7-9 h; surgical duration-adjusted odds ratio, 3.50; 95% confidence interval, 1.20-10.2; P < 0.05). The association between sleep duration and prevalence of cognitive decline was limited to the early postoperative period (at 1 week and 1 month). Among the cognitive domains assessed, attentional function was significantly impaired in patients with a sleep duration < 5 h [vs. 7-9 h at 1 week; 4/37 (10.8%) vs. 0/73 (0%); P < 0.05]. In conclusion, sleep duration < 5 h on the night before surgery was significantly associated with worse attentional function after surgery and higher incidence of cognitive decline. The present results indicate that sleep deprivation on the night before surgery may have a temporary but significantly negative influence on the patient's postoperative cognitive function and is a potential target for preventing cognitive decline.Entities:
Keywords: aging; cognitive dysfunction; elderly; postoperative complications; sleep
Year: 2022 PMID: 35153727 PMCID: PMC8831239 DOI: 10.3389/fnagi.2021.821425
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.750
Figure 1STROBE flow diagram for the included patients. Four hundred and fifty patients were approached for study participation, and 321 were enrolled after providing written informed consent. Subsequently, 127 patients were excluded, leaving 194 patients for the final analysis. ASA-PS, American Society of Anesthesiologists Physical Status.
Participants' preoperative characteristics.
|
| ||||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
| ||||||
| Age, years | 72.8 (5.3) | 74.4 (6.3) | 72.5 (4.8) | 72.3 (4.7) | 72.9 (6.4) | 0.241 |
| Female | 93 (48%) | 15 (41%) | 32 (48%) | 38 (52%) | 8 (44%) | 0.715 |
| Height, cm | 158.3 (9.0) | 158.1 (8.8) | 159.4 (1.0) | 157.3 (8.0) | 158.8 (10.4) | 0.584 |
| Weight, kg | 59.0 (10.6) | 58.3 (10.7) | 59.8 (12.2) | 58.1 (9.5) | 61.0 (9.1) | 0.647 |
| BMI | 23.5 (3.5) | 23.3 (3.8) | 23.4 (3.8) | 23.5 (3.1) | 24.3 (3.4) | 0.798 |
| ASA-PS | 2 (2–3) | 2 (2–3) | 2 (2–3) | 2 (2–2) | 2 (2–2) | 0.293 |
| Cerebrovascular accident | 12 (6.2%) | 5 (13.5%) | 3 (4.5%) | 3 (4.1%) | 1 (5.6%) | 0.235 |
| Diabetes | 56 (28.9%) | 13 (35.1%) | 21 (31.8%) | 18 (24.7%) | 4 (22.2%) | 0.576 |
| Hypertension | 88 (45.4%) | 17 (45.9%) | 29 (43.9%) | 34 (46.6%) | 8 (44.4%) | 0.996 |
| Smoking | 84 (43.3%) | 19 (51.4%) | 30 (45%) | 30 (41%) | 5 (28%) | 0.400 |
| Serum CRP, mg/L | 0.40 (1.11) | 0.63 (1.28) | 0.53 (1.59) | 0.20 (0.25) | 0.33 (0.44) | 0.222 |
| Hypnotics | 23 (11.9%) | 4 (10.8%) | 9 (13.6%) | 8 (11.0%) | 2 (11.1%) | 0.962 |
| Antipsychotics | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | NA |
| Antidepressants | 2 (1.0%) | 1 (2.7%) | 1 (2.7%) | 0 (0%) | 0 (0%) | 0.549 |
| Anxiolytics | 2 (1.0%) | 1 (2.7%) | 1 (2.7%) | 0 (0%) | 0 (0%) | 0.549 |
| Mood stabilizers | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | NA |
| Antihistamine drug | 7 (3.6%) | 3 (8.1%) | 2 (3.0%) | 1 (1.4%) | 1 (5.6%) | 0.325 |
|
| ||||||
| MMSE | 27.9 (1.7) | 28.0 (1.8) | 28.0 (1.7) | 28.0 (1.6) | 27.3 (2.0) | 0.429 |
| Mild cognitive impairment (MMSE <28) | 62 (32.0%) | 14 (37.8%) | 17 (25.8%) | 24 (32.9%) | 7 (38.9%) | 0.525 |
| RAVLT | 40.3 (10.6) | 38.5 (9.9) | 40.5 (10.1) | 41.9 (10.2) | 36.9 (14.1) | 0.206 |
| TMT | 48.9 (28.3) | 59.2 (39.2) | 49.5 (30.1) | 44.6 (20.9) | 43.0 (12.9) | 0.058 |
| LFT | 9.6 (3.5) | 8.6 (3.5) | 9.4 (3.4) | 10.4 (3.6) | 8.7 (3.0) | 0.044 |
| CFT | 15.5 (4.2) | 15.4 (4.1) | 15.3 (4.6) | 15.7 (4.1) | 14.9 (3.6) | 0.864 |
|
| ||||||
| PSQ index | 5.4 (3.4) | 5.3 (3.4) | 5.5 (3.8) | 5.2 (3.3) | 5.8 (2.6) | 0.914 |
| Daily sleep duration, min | 386 (80) | 384 (89) | 381 (77) | 397 (79) | 365 (75) | 0.423 |
| Sleep duration on the night before surgery, min | 398 (113) | 223 (61) | 272 (32) | 464 (30) | 589 (50) | <0.001 |
|
| ||||||
| Surgical duration, min | 249 (154) | 298 (200) | 207 (133) | 155 (106) | 105 (89) | <0.001 |
|
| ||||||
| Propofol | 98 (50.5%) | 15 (40.5%) | 36 (54.5%) | 39 (53.4%) | 8 (44.4%) | 0.491 |
| Desflurane | 73 (37.6%) | 15 (40.5%) | 25 (37.9%) | 26 (35.6%) | 7 (38.9%) | 0.965 |
| Sevoflurane | 23 (11.9%) | 7 (18.9%) | 5 (7.6%) | 8 (11.0%) | 3 (16.7%) | 0.337 |
|
| ||||||
| Propofol, mg | 1,187 (690) | 1,148 (632) | 1,080 (500) | 699 (234) | 0.019 | |
| Desflurane, mL | 200 (94) | 135 (71) | 110 (61) | 93 (74) | <0.001 | |
| Sevoflurane, mL | 95 (48) | 63 (27) | 47 (30) | 29 (17) | <0.001 | |
|
| ||||||
| mHR, beats/min | 62 (9) | 62 (9) | 61 (9) | 61 (9) | 62 (9) | 0.738 |
| mBP, mmHg | 72 (11) | 72 (14) | 72 (8) | 74 (12) | 72 (5) | 0.528 |
| mBIS | 46 (6) | 46 (5) | 45 (4) | 47 (8) | 47 (6) | 0.280 |
| mEtCO2, cmH2O | 39 (3) | 39 (3) | 39 (3) | 39 (3) | 38 (2) | 0.367 |
ASA-PS, ASA Physical Status; CRP, C-reactive protein; MMSE, Mini Mental State Examination; RAVLT, Rey auditory verbal learning test; TMT, Trail making test; LFT, Letter fluency test; CFT, Category fluency test; PSQ, Pittsburg Sleep Quality; SD, standard deviation; mean HR, mean heart rate; mBP, mean blood pressure; mBIS, mean bispectral index; mEtCO.
Dunnett test (vs. 7–9 h), P = 0.0305.
Dunnett test (vs. 7–9 h), P <0.001.
Dunnett test (vs. 7–9 h), P = 0.035.
Dunnett test (vs. 7–9 h), P = 0.012.
Unadjusted and adjusted incidence of cognitive decline according to sleep duration.
|
| |||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||
|
| |||||||
|
|
|
|
|
|
| ||
|
| |||||||
| Unadjusted | 2.67 (1.01–7.04) | 0.048 | 2.02 (0.842–4.83) | 0.115 | Ref | 1.8 (0.492–6.58) | 0.374 |
| Adjusted model 1 (surgical duration-adjusted) | 3.50 (1.20– 10.2) | 0.022 | 1.79 (0.730–4.38) | 0.203 | Ref | 1.82 (0.484–6.86) | 0.375 |
| Adjusted model 2 (3 variables) | 3.85 (1.26–11.8) | 0.018 | 1.77 (0.723–4.35) | 0.211 | Ref | 1.62 (0.404–6.48) | 0.496 |
| Adjusted model 3 (5 variables) | 4.30 (1.20–12.5) | 0.024 | 1.77 (0.715–4.40) | 0.216 | Ref | 1.50 (0.360–6.29) | 0.576 |
Adjusted model 2: adjusted for surgical duration, age, and sex. Adjusted model 3: adjusted for covariates included in model 2 plus MMSE score and the history of cerebrovascular accident.
Figure 2Association between sleep duration and the incidence of POCD. A U-shaped association was found between sleep duration on the night before surgery and incidence of POCD. The group with a sleep duration of 7–9 h exhibited the lowest incidence of POCD at 6 months after surgery. The logistic regression analysis demonstrated that the incidence of POCD was significantly elevated for the patients with a sleep duration <5 h, compared with the reference sleep duration (7–9 h). POCD, postoperative cognitive dysfunction. *P < 0.05.
Association between sleep duration and prevalence of cognitive decline at each time point.
|
| |||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||
|
| |||||||
|
|
|
|
|
|
| ||
|
| |||||||
| 1 week | 11.8 (1.17–119) | 0.036 | 2.78 (0.266–29.0) | 0.393 | Ref | 4.32 (0.235–79.6) | 0.325 |
| 1 month | 15 (1.5–150) | 0.021 | 3.58 (0.35–36.6) | 0.282 | Ref | 6.1 (0.303–123) | 0.238 |
| 3 months | 1.89 (0.476–7.480) | 0.366 | 1.98 (0.664–5.93) | 0.220 | Ref | 1.99 (0.43–9.2) | 0.379 |
| 6 months | 2.71 (0.662–11.1) | 0.166 | 1.68 (0.51–5.54) | 0.394 | Ref | 0.949 (0.0993–9.08) | 0.964 |
Prevalence of a significant decrease in each test score (>1 SD from the baseline).
|
| |||||
|---|---|---|---|---|---|
|
|
|
|
| ||
|
|
|
|
| ||
|
| |||||
|
|
| ||||
| RAVLT (memory) | 1 (2.7%) | 2 (3.0%) | 0 (0%) | 0 (0%) | 0.422 |
| TMT (attention) | 4 (10.8%) | 4 (6.1%) | 0 (0%) | 1 (5.6%) | 0.023 |
| LFT (letter fluency) | 4 (10.8%) | 3 (4.5%) | 9 (12.3%) | 2 (11.1%) | 0.354 |
| CFT (category fluency) | 10 (27.0%) | 11 (16.7%) | 8 (11.0%) | 3 (16.7%) | 0.210 |
|
|
| ||||
| RAVLT (memory) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | NA |
| TMT (attention) | 3 (8.1%) | 6 (9.1%) | 2 (2.7%) | 1 (5.6%) | 0.377 |
| LFT (letter fluency) | 2 (5.4%) | 3 (4.5%) | 8 (11.0%) | 2 (11.1%) | 0.422 |
| CFT (category fluency) | 12 (32%) | 15 (23%) | 9 (12%) | 5 (28%) | 0.065 |
RAVLT, Rey auditory verbal learning test; TMT, Trail-making test; LFT, Letter fluency test; CFT, Category fluency test.